Immediate early hsv-2 viral protein icp27 as vaccine

Details Immediate early hsv-2 viral protein icp27 as vaccine Immediate early hsv-2 viral protein icp27 as vaccine

C - Chemistry, Metallurgy

12

N

C12N 15/38 (2006.01) A61K 39/015 (2006.01) A61K 39/245 (2006.01) A61K 39/29 (2006.01) A61K 39/39 (2006.01) C07K 14/035 (2006.01) C12N 15/62 (2006.01)

Patent

CA 2138996

2138996 9400575 PCTABS00030 Immediate early HSV-2 viral protein ICP27 recognised by cytolytic T-lymphocyte (CTL) cells in humans, methods for preparation thereof and use in vaccine.

Affiliated with

Also associated with

Rating

Immediate early hsv-2 viral protein icp27 as vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immediate early hsv-2 viral protein icp27 as vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immediate early hsv-2 viral protein icp27 as vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1447650